Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years

The Journal of Hospital Infection
F Álvarez-LermaENVIN-HELICS Study Group

Abstract

Invasive device-associated infections caused by Pseudomonas aeruginosa over 10 years (2007-2016) were assessed based on data from the ENVIN-HELICS registry (200 Spanish intensive care units). P. aeruginosa was the leading pathogen except in the last two years in which there was a slight decrease, with Escherichia coli as the leading aetiology. The rate of infections caused by P. aeruginosa remained between 12.0% and 14.6% throughout the study period. There was a significant increase of isolates resistant to imipenem, meropenem, ceftazidime, cefepime, and piperacillin-tazobactam. Multidrug-resistant and the sum of extensively drug- and pandrug-resistant strains also increased. Resistance to anti-pseudomonal antimicrobials remains a matter of concern.

Citations

Oct 6, 2019·The Journal of Antimicrobial Chemotherapy·Stamatis KarakonstantisAchilleas Gikas
Jul 16, 2021·Food Science & Nutrition·Mingcan QinShujun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Lina M VillaGREBO
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Laura ZamoranoAntonio Oliver
DICP : the Annals of Pharmacotherapy
M BalaguéJ M Arnau
© 2022 Meta ULC. All rights reserved